12 Best Small Cap Pharma Stocks to Buy Now

Page 10 of 10

1. Indivior PLC (NASDAQ:INDV)

Number of Hedge Fund Holders: 35

Indivior PLC (NASDAQ:INDV) specializes in treatments for opioid addiction and serious mental illnesses and tops the list of the best pharmaceutical stocks. Its main products include buprenorphine-based medications like Sublocade, Suboxone, and Subutex for opioid use disorder (OUD), as well as Perseris for schizophrenia. With around 85% of its revenue coming from the U.S., the company focuses on addressing the opioid crisis and developing innovative treatments for substance use disorders and mental health conditions, positioning itself as a key player in this critical and expanding market.

Indivior PLC (NASDAQ:INDV)’s Q4 2024 financial results show steady growth, with total net revenue reaching $298 million, a 2% increase from the previous year. The company’s key product, Sublocade, saw a 10% increase in net revenue, reaching $194 million. Full-year 2024 performance was even stronger, with total net revenue rising by 9% to $1.188 billion, and Sublocade’s revenue surging by 20% to $756 million. The company also maintained a healthy adjusted gross margin of 83% and a stable adjusted operating profit of $66 million in Q4.

Looking ahead, Indivior PLC (NASDAQ:INDV)’s growth strategy revolves around Sublocade, which is expected to reach a peak net revenue of over $1.5 billion. The company is focusing on cost reductions and reinvesting savings into expanding Sublocade’s market presence and advancing its pipeline in opioid use disorder (OUD) treatments. For 2025, the corporation forecasts total net revenue between $955 million and $1.025 billion, with Sublocade revenue projected at $725 million to $765 million.

Overall, Indivior PLC (NASDAQ:INDV) ranks first among the 12 best small cap pharma stocks to buy now. While we acknowledge the potential of pharma companies, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than INDV but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 10 of 10